Skip to main content

ChronoScale Holdings Corp

corporate_fare Company Profile

ChronoScale Holdings Corp

CHRN·NASDAQ·Technology·CIK 0001549084

ChronoScale Holdings Corp operates its business through two wholly-owned subsidiaries: ChronoScale Corporation (formerly Applied Digital Cloud Corporation) and Ekso Bionics, Inc. Through ChronoScale Corporation, the company provides cloud services to customers at third-party colocation centers in Colorado, Minnesota, and Utah. These services support artificial intelligence and machine learning developers in developing advanced products. Customers pay a fixed rate for energized space supported by ChronoScale Corporation-provided equipment. Through Ekso Bionics, Inc., the company designs, develops, and markets exoskeleton and complementary products that augment human strength, endurance, and mobility. On May 29, 2026, the Board of Directors committed to a plan to divest the Ekso Bionics, Inc. business and focus operations solely on the cloud business, a plan publicly announced on June 4, 2026. The divestiture of Ekso Bionics, Inc. is expected to be completed during fiscal year 2027, and this business has been designated as "held for sale." On May 5, 2026, the company completed a business combination transaction, where Ekso Bionics Holdings, Inc. changed its name to "ChronoScale Corporation" and ChronoScale Corporation (formerly Applied Digital Cloud Corporation) became a wholly-owned subsidiary of Ekso Bionics Holdings, Inc.

ChronoScale Holdings Corp (NASDAQ:CHRN) is a publicly traded company in the Technology sector. Wiseek has independently scored 17 items for CHRN at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-21, rated 8/10. Across its 17 most recent items scored 7 or higher, the top rating is 10/10, with 13 rated 8 or above. Recent SEC coverage for CHRN spans SCHEDULE 13D/A, 8-K/A, 8-K, 10-Q.

Recent high-impact activity:

  • Applied Digital Lifts ChronoScale Stake to 85.6% Via $97M Convertible Note
  • ChronoScale Closes $153M Placement and $220M JV Note; Files Macquarie Term Loan and STN Warrant
  • ChronoScale Raises $153M Common Plus $500M Preferred Facility, Forms 50/50 STN JV With $7.5B GPU Contract
  • ChronoScale Forms 50/50 AI Data Center Venture With STN, Lands $7.5B Contract and $750M Financing
  • ChronoScale Revenue Jumps 148% but Costs Outpace Sales, Net Loss Widens to $26.4M

Financial Snapshot

Fiscal year ended May 31, 2026
Revenue
$71.6M
Net Income
-$50.32M
Diluted EPS
-$0.36
Op. Cash Flow
$39.07M
Free Cash Flow
$12.19M
Gross Profit
-$17.09M
Operating Income
-$37.5M
Cash & Equivalents
$9.66M
Total Debt
$3.84M
Debt / Equity
0.02×
Net Margin
-70.3%
Shares Outstanding
145.21M sh
Source: 10-K · filed 2026-08-19 · accession 0001628280-26-058018

Short Interest & Short Volume

4.42 days to cover

FINRA reported short interest of 598,286 shares in CHRN as of the October 30, 2026 settlement, a 6.8% decrease from the prior period — about 4.4 days to cover at its recent average daily volume. On November 20, 2026, 78.6% of CHRN volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)598,286 shares as of October 30, 2026
Change vs prior period▼ 6.8%
Days to cover4.42 at avg daily volume of 135,223
Daily short volume (FINRA facilities)78.6% of 88,254 shares on November 20, 2026
5-day average short volume71.0%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

Low risk

Filing-implied dilution signals for CHRN, detected from its recent SEC filings · based on capital-structure filings through 2026-11-18.

2 shelf registrations

Two-Part Private Placement Executed · Dilution and Preferred Terms

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with C →
$7.8 -1.89% today
52-week range · as of 2026-11-21 $3.5 – $30
Market cap
$1.16B
Volume
226K (1.2× avg)
3-mo avg 180.9K
Live data · 2026-11-22 11:32 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed CHRN - Latest Insights

CHRN
Nov 20, 2026, 8:00 PM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Price at Filing: $7.80
Real-time Price: $7.80 info
Change: $0 (0%) info
Market Cap: $1.159B info
CHRN
Nov 18, 2026, 5:18 PM EST
Filing Type: 8-K/A
Importance Score:
8
Price at Filing: $9.57
Real-time Price: $7.80 info
Change: -$1.77 (-18%) info
Market Cap: $1.159B info
CHRN
Nov 18, 2026, 8:15 AM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $8.85
Real-time Price: $7.80 info
Change: -$1.05 (-12%) info
Market Cap: $1.159B info
CHRN
Nov 18, 2026, 8:15 AM EST
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $8.85
Real-time Price: $7.80 info
Change: -$1.05 (-12%) info
Market Cap: $1.159B info
CHRN
Oct 15, 2026, 4:30 PM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $16.05
Real-time Price: $7.80 info
Change: -$8.25 (-51%) info
Market Cap: $1.159B info
CHRN
Oct 14, 2026, 4:14 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $14.88
Real-time Price: $7.80 info
Change: -$7.08 (-48%) info
Market Cap: $1.159B info
CHRN
Oct 02, 2026, 5:27 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $19.21
Real-time Price: $7.80 info
Change: -$11.41 (-59%) info
Market Cap: $1.159B info
CHRN
Oct 01, 2026, 5:40 PM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $20.29
Real-time Price: $7.80 info
Change: -$12.49 (-62%) info
Market Cap: $1.159B info
CHRN
Sep 22, 2026, 5:15 PM EDT
Filing Type: PRER14A
Importance Score:
7
Price at Filing: $21.62
Real-time Price: $7.80 info
Change: -$13.82 (-64%) info
Market Cap: $1.159B info
CHRN
Aug 27, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $20.74
Real-time Price: $7.80 info
Change: -$12.93 (-62%) info
Market Cap: $1.159B info
CHRN
Aug 27, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $22.90
Real-time Price: $7.80 info
Change: -$15.10 (-66%) info
Market Cap: $1.159B info
CHRN
Aug 19, 2026, 5:16 PM EDT
Filing Type: 10-K
Importance Score:
8
Price at Filing: $24.21
Real-time Price: $7.80 info
Change: -$16.41 (-68%) info
Market Cap: $1.159B info
CHRN
Jun 30, 2026, 5:14 PM EDT
Filing Type: 8-K/A
Importance Score:
8
Price at Filing: $22.66
Real-time Price: $7.80 info
Change: -$14.86 (-66%) info
Market Cap: $1.159B info
CHRN
Jun 26, 2026, 4:50 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $22.09
Real-time Price: $7.80 info
Change: -$14.29 (-65%) info
Market Cap: $1.159B info
CHRN
Jun 04, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $23.31
Real-time Price: $7.80 info
Change: -$15.51 (-67%) info
Market Cap: $1.159B info
CHRN
May 20, 2026, 5:14 PM EDT
Filing Type: 8-K/A
Importance Score:
8
Price at Filing: $15.35
Real-time Price: $7.80 info
Change: -$7.55 (-49%) info
Market Cap: $1.159B info
CHRN
May 12, 2026, 8:30 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
10
Price at Filing: $14.38
Real-time Price: $7.80 info
Change: -$6.58 (-46%) info
Market Cap: $1.159B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets